Steven Cohen's CAI Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 1.86 M shares of Caris Life Sciences, Inc. (CAI) worth $50.31 M, representing 0.06% of the portfolio. First purchased in 2025-Q2, this short-term holding has been held for 3 quarters.
Based on 13F filings, Steven Cohen has maintained this position in CAI for several quarters, showing initial confidence in the investment. Largest addition occurred in Q4 2025, adding 1.62 M shares. Largest reduction occurred in Q3 2025, reducing 211,852 shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Caris Life Sciences (CAI) Holding Value Over Time
Track share changes against reported price movement
Quarterly Caris Life Sciences (CAI) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +1.62 M | Add 656.16% | 1.86 M | $26.98 |
| Q3 2025 | -211,852 | Reduce 46.21% | 246,624 | $30.25 |
| Q2 2025 | +458,476 | New Buy | 458,476 | $26.72 |
Steven Cohen's Caris Life Sciences Investment FAQs
Steven Cohen first purchased Caris Life Sciences, Inc. (CAI) in Q2 2025, acquiring 458,476 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Caris Life Sciences, Inc. (CAI) for 3 quarters since Q2 2025.
Steven Cohen's largest addition to Caris Life Sciences, Inc. (CAI) was in Q4 2025, adding 1,864,860 shares worth $50.31 M.
According to the latest 13F filing for Q4 2025, Steven Cohen's firm, Point72 Asset Management, L.P., owns 1,864,860 shares of Caris Life Sciences, Inc. (CAI), valued at approximately $50.31 M.
As of the Q4 2025 filing, Caris Life Sciences, Inc. (CAI) represents approximately 0.06% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Caris Life Sciences, Inc. (CAI) was 1,864,860 shares, as reported at the end of Q4 2025.